{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:01Z","timestamp":1792801981919,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ASISA Foundation, Madrid, Spain"},{"name":"Society of Nuclear Medicine and Molecular Imaging Education and Research Foundation","id":[{"id":"https:\/\/ror.org\/024a5cr96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32EB013180"],"award-info":[{"award-number":["T32EB013180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Health Central America Institute, San Jose, Costa Rica"},{"DOI":"10.13039\/100000065","name":"NIH National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["U01NS086659"],"award-info":[{"award-number":["U01NS086659"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH National Institute of Mental Health","award":["R01MH100350"],"award-info":[{"award-number":["R01MH100350"]}]},{"name":"NIH National Institute for Neurological Disorders and Stroke","award":["R21 NS090243"],"award-info":[{"award-number":["R21 NS090243"]}]},{"name":"National Parkinson's Foundation","id":[{"id":"https:\/\/ror.org\/005aa3k38","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EB014894"],"award-info":[{"award-number":["R01 EB014894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG026484"],"award-info":[{"award-number":["R01 AG026484"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG034556"],"award-info":[{"award-number":["R01 AG034556"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 AG00513421"],"award-info":[{"award-number":["P50 AG00513421"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AG036694"],"award-info":[{"award-number":["P01 AG036694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AG10483"],"award-info":[{"award-number":["U19 AG10483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R13 AG042201174210"],"award-info":[{"award-number":["R13 AG042201174210"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG027435"],"award-info":[{"award-number":["R01 AG027435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21 AG038994"],"award-info":[{"award-number":["R21 AG038994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 AG037497"],"award-info":[{"award-number":["R01 AG037497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"crossref","award":["ZEN-10-174210K"],"award-info":[{"award-number":["ZEN-10-174210K"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Massachusetts Alzheimer\u00b4s Disease Research Center","award":["AG005134"],"award-info":[{"award-number":["AG005134"]}]},{"name":"NIH National Institute on Aging","award":["AG005134"],"award-info":[{"award-number":["AG005134"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NIH National Institute on Aging","award":["AG036694"],"award-info":[{"award-number":["AG036694"]}],"id":[{"id":"https:\/\/ror.org\/049v75w11","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0482-0","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T04:10:56Z","timestamp":1508299856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case"],"prefix":"10.1186","volume":"5","author":[{"given":"Marta","family":"Marqui\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline E.","family":"Verwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery C.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Ji Who","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthya","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Makaretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Siao Tick Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prianca","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Vanderburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Gomperts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7977-2075","authenticated-orcid":false,"given":"Teresa","family":"G\u00f3mez-Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2967\/jnumed.116.175273","volume":"58","author":"SL Baker","year":"2017","unstructured":"Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ (2017) Reference tissue-based kinetic evaluation of 18F-AV-1451 for tau imaging. J Nucl Med 58:332\u2013338. doi:\n                    10.2967\/jnumed.116.175273","journal-title":"J Nucl Med"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2967\/jnumed.116.182881","volume":"58","author":"O Barret","year":"2017","unstructured":"Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T et al (2017) Kinetic modeling of the tau PET tracer 18F-AV-1451 in human healthy volunteers and Alzheimer disease subjects. J Nucl Med 58:1124\u20131131. doi: \n                    10.2967\/jnumed.116.182881","journal-title":"J Nucl Med"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"482_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"482_CR5","doi-asserted-by":"publisher","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J et al (2016) Tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease. Sci Transl med 8: 338ra366 Doi doi: \n                    10.1126\/scitranslmed.aaf2362","DOI":"10.1126\/scitranslmed.aaf2362"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for Frontotemporal lobar degeneration. Acta Neuropathol 114:5\u201322. doi:\n                    10.1007\/s00401-007-0237-2","journal-title":"Acta Neuropathol"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.0000000000004364","volume":"89","author":"H Cho","year":"2017","unstructured":"Cho H, Baek MS, Choi JY, Lee SH, Kim JS, Ryu YH, Lee MS, Lyoo CH (2017) 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome. Neurology 89:1170\u20131178. doi:\n                    10.1212\/WNL.0000000000004364","journal-title":"Neurology"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","volume":"87","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Lee JH, Kim YJ, Lee HM, Lyoo CH, Ryu YH, Lee MS (2016) Tau PET in Alzheimer disease and mild cognitive impairment. Neurology 87:375\u2013383. doi:\n                    10.1212\/WNL.0000000000002892","journal-title":"Neurology"},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mds.26844","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, Lyoo CH (2017) Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy. Mov Disord 32:134\u2013140. doi: \n                    10.1002\/mds.26844","journal-title":"Mov Disord"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.26857","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Lee SH, Ryu YH, Lee MS, Lyoo CH (2017) 18 F-AV-1451 binds to putamen in multiple system atrophy. Mov Disord 32:171\u2013173. doi:\n                    10.1002\/mds.26857","journal-title":"Mov Disord"},{"key":"482_CR11","doi-asserted-by":"publisher","unstructured":"Coakeley S, Cho SS, Koshimori Y, Rusjan P, Harris M, Ghadery C, Kim J, Lang AE, Wilson A, Houle Set al (2017) Positron emission tomography imaging of tau pathology in progressive supranuclear palsy. J Cereb Blood Flow Metab 37: 3150-3160 doi: \n                    10.1177\/0271678X16683695","DOI":"10.1177\/0271678X16683695"},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9:179\u2013194. doi:\n                    10.1006\/nimg.1998.0395","journal-title":"NeuroImage"},{"key":"482_CR13","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1038\/tp.2016.175","volume":"6","author":"DL Dickstein","year":"2016","unstructured":"Dickstein DL, Pullman MY, Fernandez C, Short JA, Kostakoglu L, Knesaurek K, Soleimani L, Jordan BD, Gordon WA, Dams-O\u2019Connor K et al (2016) Cerebral [18 F]T807\/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy. Transl Psychiatry 6:e900. doi:\n                    10.1038\/tp.2016.175","journal-title":"Transl Psychiatry"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B (2012) FreeSurfer. NeuroImage 62:774\u2013781. doi:\n                    10.1016\/j.neuroimage.2012.01.021","journal-title":"NeuroImage"},{"key":"482_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/nimg.1998.0396","volume":"9","author":"B Fischl","year":"1999","unstructured":"Fischl B, Sereno MI, Dale AM (1999) Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage 9:195\u2013207. doi:\n                    10.1006\/nimg.1998.0396","journal-title":"NeuroImage"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40:812","journal-title":"Arch Gen Psychiatry"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016) Tau positron emission Tomographic imaging in the Lewy body diseases. JAMA Neurol 73:1334\u20131341. doi:\n                    10.1001\/jamaneurol.2016.3338","journal-title":"JAMA Neurol"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/aww139","volume":"139","author":"BA Gordon","year":"2016","unstructured":"Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ et al (2016) The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain 139:2249\u20132260. doi:\n                    10.1093\/brain\/aww139","journal-title":"Brain"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/mds.26727","volume":"32","author":"J Hammes","year":"2017","unstructured":"Hammes J, Bischof GN, Giehl K, Faber J, Drzezga A, Klockgether T, van Eimeren T (2017) Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy. Mov Disord 32:170\u2013171. doi:\n                    10.1002\/mds.26727","journal-title":"Mov Disord"},{"key":"482_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/mds.26961","volume":"32","author":"AK Hansen","year":"2017","unstructured":"Hansen AK, Damholdt MF, Fedorova TD, Knudsen K, Parbo P, Ismail R, Ostergaard K, Brooks DJ, Borghammer P (2017) In vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography. Mov Disord 32:922\u2013927. doi:\n                    10.1002\/mds.26961","journal-title":"Mov Disord"},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/brain\/aww098","volume":"139","author":"AK Hansen","year":"2016","unstructured":"Hansen AK, Knudsen K, Lillethorup TP, Landau AM, Parbo P, Fedorova T, Audrain H, Bender D, Ostergaard K, Brooks DJ et al (2016) In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET. Brain 139:2039\u20132049. doi:\n                    10.1093\/brain\/aww098","journal-title":"Brain"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566\u2013572","journal-title":"Br J Psychiatry"},{"key":"482_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 8:1\u201313. doi:\n                    10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"482_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK et al (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365. doi:\n                    10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurol"},{"key":"482_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE et al (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598. doi:\n                    10.1002\/ana.23659","journal-title":"Ann Neurol"},{"key":"482_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K et al (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79:110\u2013119. doi:\n                    10.1002\/ana.24546","journal-title":"Ann Neurol"},{"key":"482_CR27","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","volume":"132","author":"KA Josephs","year":"2016","unstructured":"Josephs KA, Whitwell JL, Tacik P, Duffy JR, Senjem ML, Tosakulwong N, Jack CR, Lowe V, Dickson DW, Murray ME (2016) [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132:931\u2013933. doi:\n                    10.1007\/s00401-016-1618-1","journal-title":"Acta Neuropathol"},{"key":"482_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J et al (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81:58\u201367. doi:\n                    10.1002\/ana.24825","journal-title":"Ann Neurol"},{"key":"482_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-161139","volume":"57","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Cho H, Werring DJ, Jang YK, Kim YJ, Lee JS, Lee J, Jun S, Park S, Ryu YH et al (2017) 18F-AV-1451 PET imaging in three patients with probable cerebral Amyloid Angiopathy. J Alzheimers Dis 57:711\u2013716. doi:\n                    10.3233\/JAD-161139","journal-title":"J Alzheimers Dis"},{"key":"482_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1162\/153535003322556877","volume":"2","author":"AM Loening","year":"2003","unstructured":"Loening AM, Gambhir SS (2003) AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2:131\u2013137","journal-title":"Mol Imaging"},{"key":"482_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T et al (2016) An autoradiographic evaluation of AV-1451 tau PET in dementia. Acta Neuropathol Commun 4:58. doi:\n                    10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"key":"482_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.24844","volume":"81","author":"M Marquie","year":"2017","unstructured":"Marquie M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Anton-Fernandez A, Klunk WE, Mathis CA, Ikonomovic MD, Debnath M et al (2017) Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol 81:117\u2013128. doi:\n                    10.1002\/ana.24844","journal-title":"Ann Neurol"},{"key":"482_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787\u2013800. doi:\n                    10.1002\/ana.24517","journal-title":"Ann Neurol"},{"key":"482_CR34","doi-asserted-by":"publisher","unstructured":"Marquie M, Siao Tick Chong M, Anton-Fernandez A, Verwer EE, Saez-Calveras N, Meltzer AC, Ramanan P, Amaral AC, Gonzalez J, Normandin MD et al (2017) [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging. Acta Neuropathol. doi:\n                    10.1007\/s00401-017-1740-8","DOI":"10.1007\/s00401-017-1740-8"},{"key":"482_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. J Alzheimers Dis 9:417\u2013423","journal-title":"J Alzheimers Dis"},{"key":"482_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1640-3","volume":"132","author":"CT McMillan","year":"2016","unstructured":"McMillan CT, Irwin DJ, Nasrallah I, Phillips JS, Spindler M, Rascovsky K, Ternes K, Jester C, Wolk DA, Kwong LK et al (2016) Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration. Acta Neuropathol 132:935\u2013937. doi:\n                    10.1007\/s00401-016-1640-3","journal-title":"Acta Neuropathol"},{"key":"482_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"482_CR38","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/tp.2014.91","volume":"4","author":"EM Mitsis","year":"2014","unstructured":"Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D'Antonio E, Martin J et al (2014) Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury. Transl Psychiatry 4:e441. doi:\n                    10.1038\/tp.2014.91","journal-title":"Transl Psychiatry"},{"key":"482_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/brain\/aww339","volume":"140","author":"M Ono","year":"2017","unstructured":"Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M et al (2017) Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain 140:764\u2013780. doi:\n                    10.1093\/brain\/aww339","journal-title":"Brain"},{"key":"482_CR40","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/brain\/aww334","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC et al (2017) Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain 140:748\u2013763. doi:\n                    10.1093\/brain\/aww334","journal-title":"Brain"},{"key":"482_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/nan.12294","volume":"42","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P et al (2016) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436\u2013450. doi:\n                    10.1111\/nan.12294","journal-title":"Neuropathol Appl Neurobiol"},{"key":"482_CR42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","volume":"12","author":"K Sander","year":"2016","unstructured":"Sander K, Lashley T, Gami P, Gendron T, Lythgoe MF, Rohrer JD, Schott JM, Revesz T, Fox NC, Arstad E (2016) Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias. Alzheimers Dement 12:1116\u20131124. doi:\n                    10.1016\/j.jalz.2016.01.003","journal-title":"Alzheimers Dement"},{"key":"482_CR43","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2967\/jnumed.115.170027","volume":"57","author":"S Shcherbinin","year":"2016","unstructured":"Shcherbinin S, Schwarz AJ, Joshi A, Navitsky M, Flitter M, Shankle WR, Devous MD Sr, Mintun MA (2016) Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment, and Alzheimer disease. J Nucl Med 57:1535\u20131542. doi:\n                    10.2967\/jnumed.115.170027","journal-title":"J Nucl Med"},{"key":"482_CR44","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Scholl M, Ohlsson T, van Swieten J, Honer M, Englund E, Hansson O (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372\u20132379. doi:\n                    10.1093\/brain\/aww163","journal-title":"Brain"},{"key":"482_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/mds.26813","volume":"32","author":"R Smith","year":"2017","unstructured":"Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hagerstrom D, Jogi J, Borroni E, Scholl M, Honer M et al (2017) Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy. Mov Disord 32:108\u2013114. doi:\n                    10.1002\/mds.26813","journal-title":"Mov Disord"},{"key":"482_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00401-016-1650-1","volume":"133","author":"R Smith","year":"2017","unstructured":"Smith R, Scholl M, Honer M, Nilsson CF, Englund E, Hansson O (2017) Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy. Acta Neuropathol 133:149\u2013151. doi:\n                    10.1007\/s00401-016-1650-1","journal-title":"Acta Neuropathol"},{"key":"482_CR47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","volume":"89","author":"R Smith","year":"2017","unstructured":"Smith R, Scholl M, Widner H, van Westen D, Svenningsson P, Hagerstrom D, Ohlsson T, Jogi J, Nilsson C, Hansson O (2017) In vivo retention of 18F-AV-1451 in corticobasal syndrome. Neurology 89:845\u2013853. doi:\n                    10.1212\/WNL.0000000000004264","journal-title":"Neurology"},{"key":"482_CR48","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"482_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/mds.26834","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Lowe VJ, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA (2017) [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy. Mov Disord 32:124\u2013133. doi:\n                    10.1002\/mds.26834","journal-title":"Mov Disord"},{"key":"482_CR50","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2967\/jnumed.115.170910","volume":"58","author":"DW Wooten","year":"2017","unstructured":"Wooten DW, Guehl NJ, Verwer EE, Shoup TM, Yokell DL, Zubcevik N, Vasdev N, Zafonte RD, Johnson KA, El Fakhri G et al (2017) Pharmacokinetic evaluation of the tau PET radiotracer 18F-T807 (18F-AV-1451) in human subjects. J Nucl Med 58:484\u2013491. doi:\n                    10.2967\/jnumed.115.170910","journal-title":"J Nucl Med"},{"key":"482_CR51","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP et al (2013) [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease. Alzheimers Dement 9:666\u2013676. doi:\n                    10.1016\/j.jalz.2012.11.008","journal-title":"Alzheimers Dement"},{"key":"482_CR52","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1038\/nprot.2006.459","volume":"1","author":"SS Yaghoubi","year":"2006","unstructured":"Yaghoubi SS, Gambhir SS (2006) PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc 1:3069\u20133075. doi:\n                    10.1038\/nprot.2006.459","journal-title":"Nat Protoc"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-017-0482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:01:24Z","timestamp":1589540484000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0482-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study and according to institutional procedures for autopsy consents for post-mortem tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Marta Marqui\u00e9 received research funding from the ASISA foundation, Madrid, Spain.Eline Verwer received research funding from the Society of Nuclear Medicine and Molecular Imaging Education and Research Foundation (Cassen Postdoctoral Mentoring Award to MDN).Sally Ji Who Kim received research funding from NIH T32\u00a0EB013180.Cinthya Ag\u00fcero received research funding from the International Health Central America Institute, San Jose, Costa Rica.Marc D. Normandin received research funding from NIH National Institute of Neurological Disorders and Stroke (U01NS086659) and NIH National Institute of Mental Health (R01MH100350).Stephen N. Gomperts received research funding from NIH National Institute for Neurological Disorders and Stroke (R21 NS090243), the National Parkinson\u2019s Foundation, and the Michael J. Fox Foundation for Parkinson\u2019s Research.Keith A. Johnson received research funding from NIH (grants R01 EB014894, R21 AG038994, R01 AG026484, R01 AG034556, P50 AG00513421, U19 AG10483, P01 AG036694, R13 AG042201174210, R01 AG027435 and R01 AG037497) and the Alzheimer\u2019s Association (ZEN-10-174,210\u00a0K). Keith A. Johnson has served as paid consultant for Bayer, GE Healthcare, Janssen Alzheimer\u2019s Immunotherapy, Siemens Medical Solutions, Genzyme, Novartis, Biogen, Roche, ISIS Pharma, AZTherapy, GEHC, Lundberg, and Abbvie. He is a site co-investigator for Lilly\/Avid, Janssen Immunotherapy and Pfizer.Matthew P. Frosch received research funding from the Massachusetts Alzheimer\u2019s Disease Research Center (NIH AG005134).Teresa G\u00f3mez-Isla received research funding from NIH National Institute on Aging (AG005134 and AG036694).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}